[PHARMA] QoQ Quarter Result on 30-Sep-2013 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- -36.04%
YoY- -85.14%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 525,072 468,672 567,860 440,807 437,633 500,339 482,404 5.82%
PBT 24,622 38,159 33,007 13,461 9,605 36,924 4,248 223.71%
Tax -8,665 -11,513 -11,740 -9,291 -3,434 -11,771 -11,716 -18.26%
NP 15,957 26,646 21,267 4,170 6,171 25,153 -7,468 -
-
NP to SH 15,975 26,217 20,813 3,751 5,865 24,771 -7,934 -
-
Tax Rate 35.19% 30.17% 35.57% 69.02% 35.75% 31.88% 275.80% -
Total Cost 509,115 442,026 546,593 436,637 431,462 475,186 489,872 2.60%
-
Net Worth 502,293 515,022 486,672 473,402 480,568 484,829 472,037 4.24%
Dividend
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Div 10,356 10,352 16,049 7,760 8,810 8,825 11,771 -8.20%
Div Payout % 64.83% 39.49% 77.11% 206.90% 150.22% 35.63% 0.00% -
Equity
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Net Worth 502,293 515,022 486,672 473,402 480,568 484,829 472,037 4.24%
NOSH 258,914 258,805 258,868 258,689 258,370 117,676 117,715 69.37%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 3.04% 5.69% 3.75% 0.95% 1.41% 5.03% -1.55% -
ROE 3.18% 5.09% 4.28% 0.79% 1.22% 5.11% -1.68% -
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 202.80 181.09 219.36 170.40 169.38 425.18 409.81 -37.51%
EPS 6.17 10.13 8.04 1.45 2.27 21.05 -6.74 -
DPS 4.00 4.00 6.20 3.00 3.41 7.50 10.00 -45.80%
NAPS 1.94 1.99 1.88 1.83 1.86 4.12 4.01 -38.45%
Adjusted Per Share Value based on latest NOSH - 258,689
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 36.43 32.52 39.40 30.59 30.37 34.72 33.47 5.82%
EPS 1.11 1.82 1.44 0.26 0.41 1.72 -0.55 -
DPS 0.72 0.72 1.11 0.54 0.61 0.61 0.82 -8.32%
NAPS 0.3485 0.3573 0.3377 0.3285 0.3334 0.3364 0.3275 4.24%
Price Multiplier on Financial Quarter End Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 -
Price 4.61 4.46 4.45 4.82 4.49 8.26 8.10 -
P/RPS 2.27 2.46 2.03 2.83 2.65 1.94 1.98 9.56%
P/EPS 74.72 44.03 55.35 332.41 197.80 39.24 -120.18 -
EY 1.34 2.27 1.81 0.30 0.51 2.55 -0.83 -
DY 0.87 0.90 1.39 0.62 0.76 0.91 1.23 -20.66%
P/NAPS 2.38 2.24 2.37 2.63 2.41 2.00 2.02 11.58%
Price Multiplier on Announcement Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 21/08/14 14/05/14 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 -
Price 4.62 4.70 4.29 4.72 4.66 9.26 7.80 -
P/RPS 2.28 2.60 1.96 2.77 2.75 2.18 1.90 12.96%
P/EPS 74.88 46.40 53.36 325.52 205.29 43.99 -115.73 -
EY 1.34 2.16 1.87 0.31 0.49 2.27 -0.86 -
DY 0.87 0.85 1.45 0.64 0.73 0.81 1.28 -22.74%
P/NAPS 2.38 2.36 2.28 2.58 2.51 2.25 1.95 14.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment